Bandhan Healthcare Fund - Regular Plan - IDCW
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 10-11-2025
AUM:
₹ 332.85 Cr
Expense Ratio
2.83%
Benchmark
BSE Healthcare TRI
ISIN
INF194KB1KD0
Minimum Investment
1000.0
Minimum Topup
1000.0
Minimum SIP Amount
100
Fund Manager
Viraj Kulkarni, Brijesh Shah
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Bandhan Healthcare Fund - Regular Plan - IDCW | - | - | - |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
10.565
Last change
0.17 (1.5902%)
Fund Size (AUM)
₹ 332.85 Cr
Performance
6.12% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors. Disclaimer: There is no assurance or guarantee that the scheme’s objectives will be realised.
Fund Manager
Viraj Kulkarni, Brijesh Shah
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 9.74 |
| Triparty Repo TRP_011026 | 6.72 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 6.18 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 5.75 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 5.27 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 4.35 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 4.27 |
| SHILPA MEDICARE LIMITED EQ NEW FV RE. 1/- | 4.17 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 4.1 |
| Dr. Reddys Laboratories Ltd | 3.78 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 92.72 |
| Financial Services | 0.83 |
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| Bandhan Healthcare Fund Reg Plan IDCW | 0.0 |